Monday, November 16, 2020

Cancer Policy Institute Newsletter: November 2020

 

Image

November 2020

Dear Advocates and Friends,

 

The one constant this year has been change and November is no exception. This month we discuss the election and share our transition document to the Biden-Harris Administration which outlines CSC’s priorities and requests to protect and promote the needs of people impacted by cancer over the next four years. We also share an infographic that illustrates the potential future of the Affordable Care Act. On November 10, the Supreme Court of the United States heard oral arguments regarding the constitutionality of the law. Our infographic provides easy to understand background information and outlines all of the potential outcomes of the case.

 

As the year winds down and we continue to navigate the pandemic, we want to thank you for your ongoing advocacy and ensure you that we will continue to bring you up-to-date information on policy issues that may have an impact on you.

Image

Elizabeth F. Franklin, PhD, MSW
Executive Director, Cancer Policy Institute

On November 10, the U.S. Supreme Court heard arguments in a legal challenge that seeks to strike down the Affordable Care Act (ACA). While the ACA remains the law of the land for now, it is important for all people, including cancer patients and survivors, to understand what this case means for them. If the Supreme Court finds that the entire ACA is unconstitutional, it could have serious impacts on access to care, removing many essential patient protections that cancer patients and survivors depend on.

Alternate text

The Cancer Support Community has created a helpful, easy-to-follow infographic that outlines the history of this landmark case and the different potential outcomes.

Clinical trials are a promising avenue for expanding treatment options and extending survival for people with cancer. However, out-of-pocket costs associated with clinical trial participation and gaps in insurance coverage create barriers for many cancer patients. By removing barriers to trial enrollment, such as coverage of routine care costs, Congress can help guarantee high-quality treatment for these patients and the inclusion of diverse populations in clinical trials.

 

The CLINICAL TREATMENT Act guarantees coverage of the routine care costs of clinical trial participation for Medicaid enrollees with life-threatening conditions, like cancer. 

Alternate text

Share your experiences navigating the health care system as a cancer patient or survivor. Your feedback will help to impact policies that affect people living with cancer! Join our 2020 Access to Care Study today. Click here.  

Alternate text

Each month, the Cancer Policy Institute profiles advocates who have been engaged in cancer advocacy. Click on the button below to learn more about Adam and his passion for early and equitable cancer detection.

CSC has created and shared with the Biden-Harris Administration a transition document that asks the incoming administration to consider a variety of recommendations and guiding principles in order to advance innovation, collaboration, and urgency in the fight against cancer, and protect and promote access to affordable and comprehensive health and cancer care.

The Cancer Support Community is hosting a virtual Precision Medicine Summit to discuss important topics in precision medicine, including biomarker testing and genetic testing for inherited cancer risk. The  Summit will also feature an advocacy panel to discuss how to talk to patients about precision medicine and to share advocacy initiatives related to precision medicine.

FacebookTwitterYouTubeInstagram
Image


Cancer Support Community

“So that No One Faces Cancer Alone”

734 15th Street NW | Suite 300
Washington, DC 20005

No comments:

Post a Comment